3/12/2025Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generati...

3/12/2025Novartis' Cosentyx Receives Fifth Indication Approval in China for Hid...

3/11/2025TYK Medicines Announces Pivotal Phase II Trial of TY-9591 Vs Osimertin...

3/11/2025Pfizer's Elrexfio Receives Conditional Approval in China for Advanced ...

3/11/2025MindRank's AI-Designed Dual Kinase Inhibitor MRANK-106 Receives FDA IN...

3/11/2025Over 100 Chinese Pharma Firms Report Losses as 319 Firms Release 2024 ...

3/10/2025China to Expand Mental Health Services Nationwide: Official

3/10/2025China Expands BMI Coverage to Over 90% of Village Clinics

3/10/2025China Approves AbbVie's Skyrizi for Active Crohn's Disease Treatment

3/10/2025The Bright Future Amidst Challenges: An Outlook on China's Pharma Econ...

3/10/2025China Biopharma Tracker – February 2025 (PharmaDJ)

3/7/2025Enhua Pharma Acquires 10.4% Stake in NeuroThree with $3.5M Investment...

3/7/2025Innovent Launches Phase 2 Trial of IBI362 for Heart Failure Patients w...

3/7/2025Recent Executive Moves

3/6/2025Nhwa Pharma Acquires Stake in Neuro3 to Expand CNS Drug Pipeline  

3/6/2025AI, Biomanufacturing, and Six Takeaways from China’s Government Work ...

3/5/2025China to Adjust Centralized Drug Procurement Policies

3/4/2025Amoytop's Strategic Acquisition of Skyline Assets Marks Expansion into...

3/4/2025BeiGene's TEVIMBRA Approved in U.S. for First-line Treatment of Advanc...

3/4/2025Trump's 'America First' Investment Policy Raises Uncertainty for US-Ch...

2/28/2025NMPA Approves Multiple Drugs for Cancer, Cardiovascular, and Liver Dis...

2/28/2025Recent Executive Moves

2/27/2025HBM Alpha Enters License Deal to Advance Novel Endocrine Therapies

2/27/2025Henlius Registers Phase 3 Trials for Keytruda and Yervoy Biosimilars

2/27/2025Biokin (SystImmune) Initiates First Autoimmune Clinical Trial for Tetr...

2/27/2025Novartis' NDA for BTK Inhibitor Remibrutinib Accepted by NMPA

2/26/2025Hengrui Reports Promising Results for Trastuzumab Rezetecan in HER2-Mu...

2/26/2025Chinese Biotech Firms Cash in on Promising Drug Discoveries via Licens...

2/25/2025XellSmart Secures Second FDA IND Approval for iPSC-Derived ALS Therapy...

2/25/2025Innovent's Dual Immunotherapy for Colon Cancer Advances with NMPA Prio...

Page:9/359 Total number of articles:10758: [First][<<] [7] [8] [9] [10] [11] [>>] [End]